Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine

Pediatric Infectious Disease Journal

Volumn 20, Issue 12, 2001, Pages 1105-1107

  Black, S B ^a   Shinefield, H R ^a   Hansen, J ^a   Elvin, L ^a   Laufer, D ^a   Malinoski, F ^a  

^a KAISER PERMANENTE   (United States)

Author keywords

Effectiveness; Pneumococcal conjugate vaccine; Postmarketing

Indexed keywords

PNEUMOCOCCUS VACCINE;

AGE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS REACTION; DRUG EFFICACY; DRUG USE; EVALUATION; HUMAN; INCIDENCE; LICENSING; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; SEROTYPING; STREPTOCOCCUS INFECTION; TREATMENT OUTCOME;

CHILD, PRESCHOOL; HUMANS; IMMUNIZATION; INCIDENCE; INFANT; MANAGED CARE PROGRAMS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; POPULATION SURVEILLANCE; PRODUCT SURVEILLANCE, POSTMARKETING; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; VACCINES, CONJUGATE;

EID: 0035666313     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200112000-00002     Document Type: Article

References (5)

1. Drug resistant Streptococcus pneumoniae: Kentucky and Tennessee, 1993
2. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
3. Effect of conjugate vaccine (PCV-7) on nasopharyngeal carriage among Native American vaccinees and their household contacts
4. Efficacy of a pneumococcal conjugate vaccine against acute otitis media